Wall Street Analysts Believe Seres Therapeutics (MCRB) Could Rally 713.09%: Here's is How to Trade

Seres Therapeutics (MCRB) closed the last trading session at $7.41, gaining 0.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 60.25 indicates a 713.1% upside potential.The average comprises four short-term price targets ranging from a low of $6 to a high of$ 200, with a standard deviation of $93.35. While the lowest estimate indicates a decline of 19% from the current price lev ...